|
|
|
|
|
|
最高研发阶段批准上市 |
|
首次获批日期1996-09-06 |
A Phase II Multicentric, Randomized, Double-blind, Placebo-controlled Study of TAR-0520 Gel in EGFR Inhibitor-induced Folliculitis.
A Phase II, multicentric, randomized, double-blind, placebo-controlled, parallel- group trial to confirm the good safaty profile and to explore the preventive effect of topically applied TAR-0520 gel on folliculitis developed in metastatic colorectal cancer (mCRC) patients treated with monoclonal anti-EGFR antibodies.
100 项与 Tarian Pharma 相关的临床结果
0 项与 Tarian Pharma 相关的专利(医药)
100 项与 Tarian Pharma 相关的药物交易
100 项与 Tarian Pharma 相关的转化医学